Publications by authors named "Sangoh Han"

Claim this Profile
N
Novel promoters drive therapeutic transgene expression and evade transgene-specific immune responses in a mouse model of Pompe disease.
Baodong Sun, Haiqing Yi, Sang-Oh Han, Songtao Li, William Eisner

Mol Genet Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-potency MyoAAV capsids enhanced skeletal muscle correction in a mouse model of GSD IIIa.
Kuo-An Liao, Sang-Oh Han, Mercedes Barzi, Haiqing Yi, William Eisner

Mol Ther Methods Clin Dev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of liver depot gene therapy in late-onset Pompe disease.
Edward C Smith, Sam Hopkins, Laura E Case, Ming Xu, Crista Walters, Stephanie Dearmey, Sang-Oh Han

Mol Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacious Androgen Hormone Administration in Combination with Adeno-Associated Virus Vector-Mediated Gene Therapy in Female Mice with Pompe Disease.
Sang-Oh Han, Dorothy Gheorghiu, Alex Chang, Sweet Hope Mapatano, Songtao Li

Hum Gene Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimum Effective Dose to Achieve Biochemical Correction with Adeno-Associated Virus Vector-Mediated Gene Therapy in Mice with Pompe Disease.
Sang-Oh Han, Dorothy Gheorghiu, Songtao Li, Hye Ri Kang, Dwight Koeberl

Hum Gene Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single phenylalanine residue in β-arrestin2 critically regulates its binding to G protein-coupled receptors.
Pierre-Yves Jean-Charles, Vishwaesh Rajiv, Subhodeep Sarker, Sangoh Han, Yushi Bai

J Biol Chem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease.
Jason Wang, Chris J Zhou, Alastair Khodabukus, Sabrina Tran, Sang-Oh Han

Commun Biol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparisons of Infant and Adult Mice Reveal Age Effects for Liver Depot Gene Therapy in Pompe Disease.
Sang-Oh Han, Songtao Li, Angela McCall, Benjamin Arnson, Jeffrey I Everitt, Haoyue Zhang

Mol Ther Methods Clin Dev· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with Pompe disease.
Sang-Oh Han, Alexina C Haynes, Songtao Li, Dennis M Abraham, Priya S Kishnani

Mol Genet Metab· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved muscle function in a phase I/II clinical trial of albuterol in Pompe disease.
Dwight D Koeberl, Laura E Case, Ankit Desai, Edward C Smith, Crista Walters, Sang-Oh Han

Mol Genet Metab· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salmeterol with Liver Depot Gene Therapy Enhances the Skeletal Muscle Response in Murine Pompe Disease.
Sang-Oh Han, Songtao Li, Jeffrey I Everitt, Dwight D Koeberl

Hum Gene Ther· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction.
Sang-Oh Han, Giuseppe Ronzitti, Benjamin Arnson, Christian Leborgne, Songtao Li

Mol Ther Methods Clin Dev· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease.
Dwight D Koeberl, Laura E Case, Edward C Smith, Crista Walters, Sang-Oh Han

Mol Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction.
Sang-Oh Han, Giuseppe Ronzitti, Benjamin Arnson, Christian Leborgne, Songtao Li

Mol Ther Methods Clin Dev· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salmeterol enhances the cardiac response to gene therapy in Pompe disease.
Sang-Oh Han, Songtao Li, Dwight D Koeberl

Mol Genet Metab· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation.
Pierre-Yves Jean-Charles, Lisheng Zhang, Jiao-Hui Wu, Sang-Oh Han, Leigh Brian

J Biol Chem· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.
Sang-Oh Han, Rand Pope, Songtao Li, Priya S Kishnani, Richard Steet

Mol Genet Metab· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.
Sang-oh Han, Songtao Li, Andrew Bird, Dwight Koeberl

Hum Gene Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade.
Sang-oh Han, Songtao Li, Elizabeth D Brooks, Elisa Masat, Christian Leborgne

Hum Gene Ther· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyubiquitin is required for growth, development and pathogenicity in the rice blast fungus Magnaporthe oryzae.
Yeonyee Oh, William L Franck, Sang-Oh Han, Angela Shows, Emine Gokce

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct roles for β-arrestin2 and arrestin-domain-containing proteins in β2 adrenergic receptor trafficking.
Sang-Oh Han, Reddy P Kommaddi, Sudha K Shenoy

EMBO Rep· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors.
Sang-oh Han, Kunhong Xiao, Jihee Kim, Jiao-Hui Wu, James W Wisler

J Cell Biol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activin A induces ovine follicle stimulating hormone beta using -169/-58 bp of its promoter and a simple TATA box.
Sang-oh Han, William L Miller

Reprod Biol Endocrinol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic gonadotropin-releasing hormone inhibits activin induction of the ovine follicle-stimulating hormone beta-subunit: involvement of 3',5'-cyclic adenosine monophosphate response element binding protein and nitric oxide synthase type I.
Farideh Shafiee-Kermani, Sang-oh Han, William L Miller

Endocrinology· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer.
Jason G Fewell, Majed Matar, Gregory Slobodkin, Sang-Oh Han, Jennifer Rice

J Control Release· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis